Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis
Clinical trial NCT06951971 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06951971
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2027-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.